TG Therapeutics Compagnie réclamée
TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. Lire la suite
HR or Marketing? Claim Your Free Employer Account
I'm proud to work alongside passionate colleagues who are driven by a shared mission to improve the lives of patients while supporting one another's growth and success.
Qu’avez-vous le plus aimé du procédé d’entretien?
Moved along quickly and communication was clear.
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
What stands out most is the people. The environment is positive, inclusive, and collaborative, with teams that genuinely support one another while staying focused on delivering meaningful outcomes for patients.
Other Employee Reviews for TG Therapeutics
×